More monitoring needed to reduce post-hospitalization urinary tract infections

Broader monitoring of patients is needed to reduce the number of people who develop a urinary tract infection after being discharged from the hospital, new research by Oregon State University suggests.

LGBT-identifying females are at increased risk of substance use in early adolescence

Females who identify as sexual minorities face an increased risk of substance use that shows up as early as age 13, suggesting early adolescence is a critical period for prevention and intervention efforts, a new study from Oregon State University has found.

CPHHS joins Planetary Health Alliance

Antibiotics that dentists prescribe are unnecessary 81% of the time, research shows

Antibiotics prescribed by dentists as a preemptive strike against infection are unnecessary 81% of the time, according to a study published today in JAMA Network Open.

Prescriptions written by pharmacists reducing risk of unwanted pregnancies

A 2016 Oregon law allowing pharmacists to write birth control prescriptions is helping more women at risk for unintended pregnancies to use contraception, new research by Oregon State University suggests.

OSU part of $1.94 million grant to study connection between autism, microbiome

An Oregon State University researcher is part of a $1.94 million grant to look for possible connections between the human microbiome and autism spectrum disorder.

Complete removal of tumor reduces risk of recurrence of cancer in dogs, analysis shows

The relative risk of a recurrence of cancer is reduced by 60% in dogs whose tumors are completely removed, a new analysis by Oregon State University researchers has found.

Researchers create standardized measurement for pediatric facial palsy

An international team of researchers has developed a standardized measurement for pediatric facial palsy that will improve the care for current and future patients with the condition.

OSU researcher gets $3.3 million grant to develop universal treatment for cystic fibrosis

A pharmaceutical sciences researcher at Oregon State University has received a five-year, $3.3 million grant from the National Institutes of Health to develop a way for cystic fibrosis patients to get molecular treatment via an inhaler, a potential vast improvement over existing therapeutic methods.

Wristband samplers show similar chemical exposure across three continents

Oregon State University researchers deployed chemical-sampling wristbands to individuals on three continents and found that no two wristbands had identical chemical detections – but the same 14 chemicals were detected in more than 50 percent of the wristbands.

Pages